Huae Xu

2.5k citations
70 papers · 2.1k indexed · h-index 27

Impact in

Papers in

Huae Xu

69 papers receiving 2.1k citations

Peers

Huae Xu
Comparison fields: 5 of 106
  • Biomaterials 558
  • Molecular Medicine 207
  • Geriatrics and Gerontology 153
  • Pharmaceutical Science 125
  • Biomedical Engineering 623
Replace Ommoleila Molavi with:
Ommoleila Molavi Iran
S. Asha Nair India
Xing Zheng China
Fabrício Figueiró Brazil
Amirhossein Zabolian Iran
Dejun Ding China
Sepideh Mirzaei Iran
Farid Hashemi Iran
Nasser Samadi Iran
Rui-Jun Ju China
Huae Xu relative to Ommoleila Molavi Iran Ommoleila Molavi's profile →
Citations per field
00.5×
Ommoleila Molavi · 1×
Citations per year

Countries citing papers authored by Huae Xu

Since Specialization
Citations

This map shows the geographic impact of Huae Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huae Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huae Xu more than expected).

Fields of papers citing papers by Huae Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huae Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huae Xu. The network helps show where Huae Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Huae Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Huae Xu Line = papers co-authored together Huae Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20244
4 20247
5 202415
6 20248
7 20240
8 20245
9 20246
10 202313
11 202243
12 202219
13 202221
14 202239
15 20227
16 2022115
17 202119
18 20217
19 202051
20 20208

About Huae Xu

Huae Xu is a scholar working on Biomaterials, Molecular Medicine, Geriatrics and Gerontology, Aging and Biomedical Engineering, having authored 70 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (23 papers), RNA Interference and Gene Delivery (16 papers), Nanoparticle-Based Drug Delivery (15 papers), Ferroptosis and cancer prognosis (7 papers), Berberine and alkaloids research (7 papers), Curcumin's Biomedical Applications (6 papers), Natural product bioactivities and synthesis (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). The work is most often cited by research in Biomaterials (558 citations), Molecular Medicine (207 citations), Geriatrics and Gerontology (153 citations), Pharmaceutical Science (125 citations) and Biomedical Engineering (623 citations). Huae Xu has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Xiaolin Li, Dan Ding, Xiaowei Lu, Donghui Zheng, Sunil Krishnan, Zhenshu Zhu, Wei‐Hao Sun, Jacky W. Y. Lam, Shenglu Ji and Ryan T. K. Kwok. Their work appears in journals such as Journal of Biomedical Nanotechnology, ACS Applied Materials & Interfaces, Advanced Functional Materials, International Journal of Pharmaceutics and International Journal of Nanomedicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026